Genetically modified msc and therapeutic methods
作者： Jan Nolta , Karen Pepper , Fernando Fierro , Gerhard Bauer
DOI:
关键词:
摘要: This disclosure relates to vectors, isolated cells, compositions, and methods for the treatment of critical limb ischemia associated disorders. One aspect a vector comprising nucleic acid encoding 165A isoform VEGF protein promoter that regulates expression VEGF.
wipo.int
lens.org 参考文章(101)
Carola Jacoba M. Ubink-Bontekoe, Folkert Feiko Roossien, Tjerk Johannes A. Visser, Vectors for enhanced expression of VEGF for atrial disease treatment ,(2002)
Michael Krause, Transcription and translation. Methods in Cell Biology. ,vol. 48, pp. 483- 512 ,(1995) , 10.1016/S0091-679X(08)61400-4
Seppo Ylä-Herttuala, Tuomas T. Rissanen, Ismo Vajanto, Juha Hartikainen, Vascular Endothelial Growth Factors Journal of the American College of Cardiology. ,vol. 49, pp. 1015- 1026 ,(2007) , 10.1016/J.JACC.2006.09.053
T. Meyerrose, I. Rosova, M. Dao, P. Herrbrich, G. Bauer, J. Nolta, Establishment and Transduction of Primary Human Stromal/Mesenchymal Stem Cell Monolayers Genetic Engineering of Mesenchymal Stem Cells. pp. 45- 58 ,(2006) , 10.1007/1-4020-3959-X_2
Savvas C. Makrides, Gene transfer and expression in mammalian cells Elsevier. ,(2003)
Genetic engineering of mesenchymal stem cells Springer Netherlands. ,(2006) , 10.1007/1-4020-3959-X
Christopher B. Reld, Methods for production and uses of multipotent ,pluripotent, differentiated and disease-resistant cell populations ,(2008)
Arthur W. Nienhuis, Elio F. Vanin, Retroviral vector particles ,(1994)
Neil Hackett, Ronald Crystal, Alternatively targeted nucleic acid molecules ,(2004)